177 related articles for article (PubMed ID: 2464940)
1. Cell proliferation in non-Hodgkin's lymphomas. Digital image analysis of Ki-67 antibody staining.
Schwartz BR; Pinkus G; Bacus S; Toder M; Weinberg DS
Am J Pathol; 1989 Feb; 134(2):327-36. PubMed ID: 2464940
[TBL] [Abstract][Full Text] [Related]
2. Proliferation markers in non-Hodgkin's lymphoma. A comparative study between cytophotometric quantitation of Ki-67 and flow cytometric proliferation index on fine needle aspirates.
Katz RL; Wojcik EM; el-Naggar AK; Ordonez NG; Johnston DA
Anal Quant Cytol Histol; 1993 Jun; 15(3):179-86. PubMed ID: 8347257
[TBL] [Abstract][Full Text] [Related]
3. The role of cell cycle activity in the generation of morphologic heterogeneity in non-Hodgkin's lymphoma.
Weinberg DS
Am J Pathol; 1989 Oct; 135(4):759-70. PubMed ID: 2801888
[TBL] [Abstract][Full Text] [Related]
4. MIB-1, Ki67, and PCNA scores and DNA flow cytometry in intermediate grade malignant lymphomas.
Pich A; Ponti R; Valente G; Chiusa L; Geuna M; Novero D; Palestro G
J Clin Pathol; 1994 Jan; 47(1):18-22. PubMed ID: 7907607
[TBL] [Abstract][Full Text] [Related]
5. Quantitative study of KI-67 antibody staining in non-Hodgkin's lymphomas using image analysis.
Caulet S; Lesty C; Raphael M; Binet JL; Diebold J
Anal Quant Cytol Histol; 1991 Aug; 13(4):279-87. PubMed ID: 1718298
[TBL] [Abstract][Full Text] [Related]
6. Comparative assessment of proliferation and DNA content in breast carcinoma by image analysis and flow cytometry.
Dawson AE; Norton JA; Weinberg DS
Am J Pathol; 1990 May; 136(5):1115-24. PubMed ID: 1972000
[TBL] [Abstract][Full Text] [Related]
7. Biological heterogeneity of diffuse mixed small and large cell non-Hodgkin's lymphomas assessed by DNA flow cytometry and Ki67.
Palestro G; Pich A; Chiusa L; Geuna M; Ponti R; Kerim S; Novero D; Valente G
Leuk Lymphoma; 1995 Nov; 19(5-6):467-72. PubMed ID: 8590848
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of Ki-67 antigen in non-Hodgkin lymphoma of Waldeyer ring and the nasal cavity.
Yamanaka N; Harabuchi Y; Kataura A
Cancer; 1992 Nov; 70(9):2342-9. PubMed ID: 1394063
[TBL] [Abstract][Full Text] [Related]
9. DNA image cytometry and the expression of proliferative markers (proliferating cell nuclear antigen and Ki67) in non-Hodgkin's lymphomas.
Czader M; Porwit A; Tani E; Ost A; Mazur J; Auer G
Mod Pathol; 1995 Jan; 8(1):51-8. PubMed ID: 7731942
[TBL] [Abstract][Full Text] [Related]
10. Analysis of proliferating cell fraction determined by monoclonal antibody to M1-subunit ribonucleotide reductase and Ki-67 in relation to p53 protein expression in fine-needle aspirates from non-Hodgkin's lymphomas.
Sviatoha V; Tani E; Rassidakis G; Tribukait B; Kleina R; Skoog L
Cytopathology; 2000 Oct; 11(5):290-301. PubMed ID: 11014656
[TBL] [Abstract][Full Text] [Related]
11. Proliferation in non-Hodgkin's lymphomas as determined by immunohistochemical double staining for Ki-67.
Tominaga K; Yamaguchi Y; Nozawa Y; Abe M; Wakasa H
Hematol Oncol; 1992; 10(3-4):163-9. PubMed ID: 1398512
[TBL] [Abstract][Full Text] [Related]
12. Assessment of cell proliferation by Ki-67 staining and flow cytometry in fine needle aspirates (FNAs) of reactive lymphadenitis and non-Hodgkin's lymphomas.
Schmitt F; Tani E; Tribukait B; Skoog L
Cytopathology; 1999 Apr; 10(2):87-96. PubMed ID: 10211614
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometric measurements of proliferation-associated nuclear antigen p105 and DNA content in non-Hodgkin's lymphomas.
Turner RR; Layfield LJ; Bishop PC; Epstein AL; Parker JW
Arch Pathol Lab Med; 1989 Aug; 113(8):907-11. PubMed ID: 2569301
[TBL] [Abstract][Full Text] [Related]
14. DNA content of T-cell lymphomas. A flow-cytometric analysis.
Egerter DA; Said JW; Epling S; Lee S
Am J Pathol; 1988 Feb; 130(2):326-34. PubMed ID: 3257649
[TBL] [Abstract][Full Text] [Related]
15. Growth fraction in non-Hodgkin's lymphomas and reactive lymphadenitis determined by Ki-67 monoclonal antibody in fine-needle aspirates.
Skoog L; Tani E; Svedmyr E; Johansson B
Diagn Cytopathol; 1995 May; 12(3):234-8; discussion 238-40. PubMed ID: 7621718
[TBL] [Abstract][Full Text] [Related]
16. Transferrin receptor expression by non-Hodgkin's lymphomas. Correlation with morphologic grade and survival.
Medeiros LJ; Picker LJ; Horning SJ; Warnke RA
Cancer; 1988 May; 61(9):1844-51. PubMed ID: 3355978
[TBL] [Abstract][Full Text] [Related]
17. Relevance of Ki-67 expression in the classification of non-Hodgkin's lymphomas: a morphometric and double-immunostaining study.
Houmand A; Abrahamsen B; Tinggaard Pedersen N
Histopathology; 1992 Jan; 20(1):13-20. PubMed ID: 1737622
[TBL] [Abstract][Full Text] [Related]
18. A comparison of nucleolar organizer region staining and Ki-67 immunostaining in non-Hodgkin's lymphoma.
Hall PA; Crocker J; Watts A; Stansfeld AG
Histopathology; 1988 Apr; 12(4):373-81. PubMed ID: 2453436
[TBL] [Abstract][Full Text] [Related]
19. Tumor proliferative fraction in solid malignant neoplasms. A comparative study of Ki-67 immunostaining and flow cytometric determinations.
Sahin AA; Ro JY; el-Naggar AK; Wilson PL; Teague K; Blick M; Ayala AG
Am J Clin Pathol; 1991 Oct; 96(4):512-9. PubMed ID: 1716414
[TBL] [Abstract][Full Text] [Related]
20. MIB1 (Ki-67) expression in non-Hodgkin's lymphomas.
Kalogeraki A; Tzardi M; Panagiotides I; Koutsoubi K; Bolioti S; Rontogianni D; Stefanaki K; Zois E; Karidi E; Darivianaki K; Delides G; Kanavaros P
Anticancer Res; 1997; 17(1A):487-91. PubMed ID: 9066700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
